You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 66 No. 5, May 2009 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  Original Contribution
 •Online Features
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (9)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Neurology
 •Multiple Sclerosis/ Demyelinating Disease
 •Radiologic Imaging
 •Diagnosis
 •Magnetic Resonance Imaging
 •Immunologic Disorders
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Progressive Multifocal Leukoencephalopathy and Relapsing-Remitting Multiple Sclerosis

A Comparative Study

Aaron Boster, MD; Stephanie Hreha, BS; Joseph R. Berger, MD; Fen Bao, MS; Ramya Penmesta, MS; Alexandros Tselis, MD, PhD; Christina Endress, BS; Imad Zak, MD; Jai Perumal, MD; Christina Caon, MSN, NP-C; Jose Vazquez, MD; Kenneth L. Tyler, MD; Michael K. Racke, MD; Scott Millis, PhD; Omar Khan, MD

Arch Neurol. 2009;66(5):593-599.

Objective  To identify clinical and magnetic resonance imaging (MRI) features that distinguish progressive multifocal leukoencephalopathy (PML) from relapsing-remitting multiple sclerosis (RRMS).

Design  Retrospective medical record review.

Setting  Two urban teaching hospitals in Detroit, Michigan.

Patients  Forty-five confirmed PML cases and 100 patients with RRMS.

Main Outcome Measures  Clinical and MRI features distinguishing PML from RRMS.

Results  Overall, monosymptomatic presentations were more common in multiple sclerosis (MS) than PML (85% vs 47%; P < .01). However, patients with PML presented more often with hemiparesis (24% vs 5%; P = .001) and altered mentation (19% vs 0%; P < .0001), whereas brainstem (2% vs 18%; P = .007) presentations were more common in patients with RRMS. Spinal cord and optic neuritis presentations were seen in 18% and 33% of patients with RRMS, respectively, but not in patients with PML (m < .0001). Brain MRI scans, available in 35 (78%) PML cases, revealed 7 lesion types. Large, confluent T2-weighted lesions (74% vs 2%; P < .0001) and deep gray matter lesions (31% vs 7%; P < .001) were more frequent in patients with PML than patients with RRMS. Crescentic cerebellar lesions (23% vs 0%; P < .001) were seen only in patients with PML. Gadolinium-enhancing (23%), transcallosal (9%), and periventricular (9%) lesions were noted in patients with PML. Brain magnetization transfer ratio (MTR) was low in both PML and MS lesions. However, normal-appearing brain tissue MTR in PML was higher than normal-appearing brain tissue MTR in RRMS (44.15% vs 41.04%; P = .002), suggesting that PML may be relatively more focal than MS.

Conclusions  There appear to be differences between the clinical and MRI characteristics of PML and RRMS, which may help distinguish new MS activity from PML. Magnetization transfer ratio studies may provide additional clues in improving early detection of PML in patients with preexisting MS and warrant further investigation.


Author Affiliations: Image Analysis Laboratory, Multiple Sclerosis Center, Department of Neurology (Drs Boster, Tselis, Zak, Perumal, and Khan and Mss Hreha, Bao, Penmesta, Endress, and Caon), Department of Radiology (Dr Zak), and Department of Physical Medicine and Rehabilitation and Division of Biostatistics and Clinical Translational Science (Dr Millis), Wayne State University School of Medicine, The Detroit Medical Center (Drs Boster, Tselis, Perumal, and Khan and Mss Hreha, Bao, Penmesta, and Caon), and Division of Infectious Diseases, Henry Ford Hospital (Dr Vazquez), Detroit, Michigan; Multiple Sclerosis Center, Division of Neuroimmunology, Department of Neurology, Ohio State University, Columbus (Drs Boster and Racke); Department of Neurology, University of Kentucky College of Medicine, Lexington (Dr Berger); and Departments of Neurology, Medicine, and Microbiology, University of Colorado Health Sciences Center and Denver Veterans Affairs Medical Center, Denver (Dr Tyler).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

This Month in Archives of Neurology
Arch Neurol. 2009;66(5):552-553.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Clinical Reasoning: An 83-year-old woman with progressive hemiataxia, tremor, and infratentorial lesions
Aquino et al.
Neurology 2011;77:e7-e10.
FULL TEXT  

Immune Reconstitution Inflammatory Syndrome in Patients With Multiple Sclerosis Following Cessation of Natalizumab Therapy
Miravalle et al.
Arch Neurol 2011;68:186-191.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.